Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
Samuel Turton(Imperial College London), Anne Lingford‐Hughes(Hammersmith Hospital), Claire Durant(Imperial College London), David Nutt(Imperial College London), Stafford L. Lightman(University of Bristol), Gemma Dawe(Imperial College Healthcare NHS Trust), Inge Mick(Imperial College London), Alan D. Brailsford(King's College London), Adam Waldman(Royal Society of Edinburgh), Roger N. Gunn(Mitsubishi Corporation (United Kingdom)), Alessandro Colasanti(Imperial College London), Ashwin Venkataraman(Imperial College London), Eugenii A. Rabiner(GlaxoSmithKline (United Kingdom)), James F. Myers(Imperial College London), Mark C. Parkin(King's College London)
Cited by 33
Related Papers
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Amphetamine, past and present – a pharmacological and clinical perspective
|Journal of Psychopharmacology|2013|614
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
|European Addiction Research|2014|442